Physician profile
Jan V Dickey
NPI 1134153752
$898.30
in general payments reported to CMS, 2019-2025
16 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.18 · 2020: $11.47 · 2021: $72.09 · 2022: $105 · 2023: $224 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $302.21 | 2020-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $85.21 | 2023-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $72.09 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $67.97 | 2025 | Dupixent |
| Abbvie INC. | $60.45 | 2023-2025 | Vraylar |
| Gilead Sciences, INC. | $56.08 | 2025 | Vemlidy |
| Indivior INC. | $52.70 | 2025 | Sublocade |
| Pfizer INC. | $30.30 | 2025 | |
| Dynavax Technologies Corporation | $27.87 | 2025 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $27.83 | 2025 | |
| Lilly USA, LLC | $22.04 | 2025 | Mounjaro |
| Amgen INC. | $20.18 | 2025 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.34 | 2025 | Xifaxan |
| Amarin Pharma, INC. | $19.18 | 2019 | |
| Xeris Pharmaceuticals, INC. | $19.09 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.76 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Dickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.